Hetero Biopharma

text/x-generic newsroom.php ( PHP script, UTF-8 Unicode text, with CRLF line terminators ) Hetero Biopharma

Official press releases and media coverage test

2022

Hetero’s ‘NIRMACOM’ is world’s first generic version of COVID-19 oral drug ‘PAXLOVID’ to receive WHO Prequalification
Hetero acquires manufacturing plant at Penjerla in Telangana, India
Hetero unveils new logo and corporate brand identity
Hetero receives CDSCO approval to manufacture Sputnik Light vaccine for sale in India
Hetero enters into a voluntary licensing agreement with MPP to expand access of nirmatrelvir & ritonavir generics for COVID-19 treatment in 95 countries.
Hetero presents positive results from Molnupiravir Phase III Studies at CROI 2022

2021

2020

2019

2018

2017

2016

Hetero Bevacizumab India

2015

2014

India, Hyderabad, 15th September 2014
Hetero Sofosbuvir Licensing agreement